© 1999 by Oxford University Press
Journal of the National Cancer Institute, Vol. 91, No. 17, 1451-1452,
September 1, 1999
© 1999 Oxford University Press
NEWS |
Awards, Appointments, Announcements
DES Action USA, a national consumer organization focused on diethylstilbesterol issues, recently presented Robert N. Hoover, M.D., with its Distinguished Service Award. Hoover is director of the Epidemiology and Biostatistics Program of the National Cancer Institute's Division of Cancer Epidemiology and Genetics.He was honored for "his tireless dedication to research benefitting the lives of DES-exposed individuals."
Ingram Professorships
Vanderbilt University's E. Bronson Ingram Cancer Center, Nashville, awarded the first Ingram Cancer Research Professorships to eight current and two new faculty members.
The new faculty members named Ingram Professors of Cancer Research are Friedrich Schuening, M.D., who directs Vanderbilt's Bone Marrow Transplant Program, and Andrew Link, Ph.D., who will be assistant professor of microbiology and immunology. Schuening had been at the University of Wisconsin, Madison, and Link has been a scientist at Millennium Predictive Medicine, Cambridge, Mass.
Current faculty members named to the professorship are Carlos L. Ateaga, M.D., professor of medicine and cell biology; David P. Carbone, M.D., Ph.D., professor of medicine and cell biology; Graham Carpenter, Ph.D., professor of biochemistry and medicine; Robert J. Coffey Jr., M.D., professor of medicine and cell biology;
|
Also, Lynn M. Matrisian, Ph.D., professor and interim chair of cell biology; J. Robert Roberts, M.D., assistant professor of cardiac and thoracic surgery; Mace L. Rothenberg, M.D., associate professor of medicine; and Earl Ruley, Ph.D., professor of microbiology and immunology.
|
|
Chiron Appointments
Chiron Corp., Emeryville, Calif., named Peder K. Jensen, M.D., corporate vice president and head of development, and named Joyce A. Lonergan division vice president of corporate development.
Jensen is responsible for managing all aspects of Chiron's product development, including preclinical, clinical, project management, and regulatory and medical affairs. Lonergan will execute corporate mergers, acquisitions, and strategic transactions.
Herschl Is New President
The new president of the Association of Oncology Social Workers is Joyce Herschl, coordinator of oncology social work services at the University of Pittsburgh Cancer Institute.
AOSW is an organization that works to increase awareness of the social, emotional, educational, and spiritual needs of cancer patients and their families.
New NCI Branch Chief
The National Cancer Institute's Division of Cancer Epidemiology and Genetics announced that Arthur Schatzkin, M.D., Dr.P.H., is the new head of its Nutritional Epidemiology Branch.
|
Schatzkin has been a member of the branch staff since 1997. His research interests are the nutritional causes and prevention of cancer.
Geron Names Okarma
Geron Corp., Menlo Park, Calif., named Thomas B. Okarma, M.D., Ph.D., as president and chief executive officer. He had been vice president of research and development at Geron.
Geron is a biopharmaceutical company that concentrates on therapeutic and diagnostic products for cancer and age-related chronic degenerative diseases.
New Medical Director
The Cancer Treatment Centers of America, Tulsa, Okla., named Richard B. Hostetter, M.D., as medical director for oncology services at Goshen (Ind.) Health System.
|
Hostetter had been assistant professor and head of the Section of Surgical Oncology at West Virginia University, Morgantown.
Pediatric Group Has New Name
Children's Oncology Group is the name of the new organization created by the merger of the four pediatric cancer research groups: The Children's Cancer Group, the Intergroup Rhabdomyosarcoma Study Group, the National Wilms' Tumor Study Group, and the Pediatric Oncology Group.
"The inspiration to form the Children's Oncology Group grew from the realization that we would all be much better off working together to achieve our common goals," said Sharon Murphy, M.D., chair of POG. COG plans to function as a single group by 2001 and to apply for its first grant in 2002.
CiteULike 
Connotea 
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||